Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$128K Sell
12,759
-3,575
-22% -$37.2K 0.01% 889
2025
Q4
$165K Hold
16,334
0.01% 866
2025
Q3
$147K Sell
16,334
-1,702
-9% -$16.4K 0.01% 865
2025
Q2
$187K Hold
18,036
0.01% 823
2025
Q1
$186K Sell
18,036
-1,879
-9% -$18.5K 0.01% 801
2024
Q4
$190K Sell
19,915
-235
-1% -$2.3K 0.01% 813
2024
Q3
$213K Buy
20,150
+750
+4% +$7.25K 0.01% 767
2024
Q2
$160K Sell
19,400
-600
-3% -$5.01K 0.01% 788
2024
Q1
$170K Sell
20,000
-600
-3% -$5.01K 0.01% 831
2023
Q4
$170K Sell
20,600
-400
-2% -$3.3K 0.01% 773
2023
Q3
$175K Sell
21,000
-990
-5% -$8.24K 0.01% 765
2023
Q2
$184K Buy
21,990
+200
+0.9% +$1.71K 0.01% 762
2023
Q1
$177K Sell
21,790
-1,439
-6% -$11.5K 0.01% 764
2022
Q4
$186K Sell
23,229
-1,389
-6% -$9.45K 0.01% 751
2022
Q3
$150K Buy
+24,618
New +$159K 0.01% 735

Other funds holding HLN

Moors & Cabot's HLN Position: Q1 2026 in Review

Moors & Cabot reduced its Haleon (HLN) stake by 22% in Q1 2026, selling an estimated $37.2K and leaving 12,759 shares worth $128K. The position accounts for 0.01% of the portfolio, ranked #889.

Moors & Cabot first reported a position in HLN in Q3 2022 and has held it in 15 quarters since. The position peaked at $213K in Q3 2024. 622 funds tracked by Wall St. Rank hold HLN as of Q1 2026.

  • Moors & Cabot held 12,759 shares of Haleon worth $128K as of Q1 2026.
  • Moors & Cabot sold 3,575 Haleon shares in Q1 2026, an estimated $37.2K.
  • Haleon made up 0.01% of Moors & Cabot's portfolio in Q1 2026, its #889 holding.
  • Moors & Cabot first reported a position in Haleon in Q3 2022 and has held it in 15 quarters since.
  • Moors & Cabot's Haleon position peaked at $213K in Q3 2024.
  • 622 funds tracked by Wall St. Rank held Haleon as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.